QSAR - Predictive Toxicology Conference -- Sept. 8-9 in Philadelphia

Presenting Barnett International's
Predictive Toxicology
Strategies to Reduce Late Stage Drug Failures and Address Bottlenecks of
In-vitro and In-vivo Toximetabolism Using High-Throughput Methods
<http://www.barnettinternational.com/RSC_PDFUploads//BI4007WEB.pdf>

September 8-9 * Park Hyatt at the Bellevue * Philadelphia, PA

$70 million of the total R&D costs per drug are spent on ADME/Tox failures!
Due to the high cost of late-stage failure and the impact of adverse drug
reactions, it is critical to eliminate toxic compounds as early as possible
in the drug development process. This comprehensive event featuring
industry, academic and agency case studies offers strategies to reduce late
stage drug failures and address bottlenecks of in-vitro and in-vivo
toximetabolism using high-throughput methods.

When registering for this conference as a member of the QSAR and Modelling
Society please request your 15% discount.

Phone: (610) 565-2622, ext. 2200
Email: customer.service%parexel.com

We look forward to seeing you in Philadelphia.

Sincerely,

Micah Lieberman
Barnett Conference Group
541.665.1236 ph
Micah.Lieberman-.-parexel.com
www.barnettinternational.com
Received on 2004-08-02 - 14:03 GMT